ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 293,72
0,55%
DAX
18 161,01
1,32%
Brent Oil
88,185
0,04%
Bitcoin
64 036,75
-0,69%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Voyager Therapeutics Inc (VYGR)

  7. Voyager Therapeutics Inc (VYGR) Actualités

VYGR Voyager Therapeutics Inc

7,60
0,18 (2,43%)
Dernière mise à jour : 20:48:44
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Voyager Therapeutics Inc VYGR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,18 2,43% 7,60 20:48:44
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
7,40 7,32 7,71 7,42
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/4/202422:30GLOBEVoyager Therapeutics to Present Broad Set of Translational..
16/4/202413:00GLOBEVoyager Therapeutics Announces Selection of Development..
26/3/202421:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
13/3/202412:00GLOBEVoyager Therapeutics Announces Appointment of Toby Ferguson..
28/2/202422:01GLOBEVoyager Therapeutics Reports Fourth Quarter and Full Year..
28/2/202422:00EDGAR2Form 8-K - Current report
26/2/202413:00GLOBEVoyager Therapeutics Announces Selection of Gene Therapy..
22/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202421:16EDGAR2Form 144 - Report of proposed sale of securities
21/2/202421:13EDGAR2Form 144 - Report of proposed sale of securities
21/2/202413:00GLOBEVoyager Therapeutics Announces Fourth Quarter 2023..
20/2/202421:11EDGAR2Form 144 - Report of proposed sale of securities
20/2/202413:00GLOBEVoyager Therapeutics Reports Robust Preclinical Activity in..
16/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202413:00GLOBEVoyager Therapeutics to Present at the Oppenheimer Annual..
19/1/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:20EDGAR2Form D - Notice of Exempt Offering of Securities
17/1/202421:33EDGAR2Form 144 - Report of proposed sale of securities
17/1/202421:21EDGAR2Form 144 - Report of proposed sale of securities
08/1/202422:49EDGAR2Form 8-K - Current report
08/1/202422:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/1/202404:45GLOBEVoyager Therapeutics Announces Pricing of Public Offering
04/1/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/1/202422:14GLOBEVoyager Therapeutics Announces Proposed Public Offering
03/1/202413:00GLOBEVoyager Therapeutics to Present at the 42nd Annual J.P...
02/1/202413:46DJNVoyager Therapeutics Shares Leap Premarket on Novartis..
02/1/202413:05EDGAR2Form 8-K - Current report
02/1/202413:00GLOBEVoyager Therapeutics Enters Capsid License Agreement and..
06/12/202313:04EDGAR2Form 8-K - Current report
06/12/202313:00GLOBEVoyager Therapeutics Announces Selection of Development..
06/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:01GLOBEVoyager Therapeutics Reports Third Quarter 2023 Financial..
06/11/202322:00EDGAR2Form 8-K - Current report
30/10/202312:00GLOBEVoyager Therapeutics Announces Third Quarter 2023 Conference..
02/10/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202313:00GLOBEVoyager Therapeutics to Present at the Chardan Genetic..
18/9/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202319:57EDGAR2Form 144 - Report of proposed sale of securities
07/9/202322:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
30/8/202313:00GLOBEVoyager Therapeutics to Participate in Upcoming Investor..
16/8/202322:18EDGAR2Form 8-K - Current report
08/8/202322:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
07/8/202314:00GLOBEVoyager Therapeutics Announces Appointment of Beth Shafer as..
03/8/202313:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202313:00EDGAR2Form 8-K - Current report
03/8/202313:00GLOBEVoyager Therapeutics Reports Second Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
VYGR
Voyager Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés